I. Expression across cell types
Name | Number of supported studies  | Average coverage | |
|---|---|---|---|
| fibroblast | 8 studies | 24% ± 7% | |
| pericyte | 7 studies | 20% ± 3% | |
| smooth muscle cell | 7 studies | 20% ± 5% | |
| classical monocyte | 5 studies | 17% ± 2% | |
| B cell | 5 studies | 18% ± 2% | |
| epithelial cell | 5 studies | 41% ± 17% | |
| non-classical monocyte | 4 studies | 22% ± 6% | |
| CD4-positive, alpha-beta T cell | 4 studies | 17% ± 2% | |
| myofibroblast cell | 4 studies | 21% ± 3% | |
| endothelial cell | 4 studies | 31% ± 7% | |
| hematopoietic stem cell | 4 studies | 19% ± 3% | |
| conventional dendritic cell | 3 studies | 23% ± 3% | |
| naive thymus-derived CD8-positive, alpha-beta T cell | 3 studies | 16% ± 2% | |
| basal cell | 3 studies | 32% ± 11% | |
| type I pneumocyte | 3 studies | 21% ± 4% | |
| ciliated cell | 3 studies | 35% ± 3% | |
| glutamatergic neuron | 3 studies | 17% ± 2% | |
| dendritic cell | 3 studies | 27% ± 10% | |
| intestinal crypt stem cell | 3 studies | 19% ± 2% | |
| connective tissue cell | 3 studies | 22% ± 6% | |
| plasmacytoid dendritic cell | 3 studies | 22% ± 3% | |
| natural killer cell | 3 studies | 21% ± 3% |
